Compare LPCN & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LPCN | VTSI |
|---|---|---|
| Founded | 1997 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 53.2M |
| IPO Year | 2011 | 1999 |
| Metric | LPCN | VTSI |
|---|---|---|
| Price | $8.17 | $4.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | $7.00 |
| AVG Volume (30 Days) | ★ 104.4K | 25.4K |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $11,198,144.00 | ★ $16,524,225.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.39 |
| P/E Ratio | ★ N/A | $46.89 |
| Revenue Growth | ★ 492.80 | 5.57 |
| 52 Week Low | $2.52 | $3.57 |
| 52 Week High | $12.37 | $7.47 |
| Indicator | LPCN | VTSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.42 | 39.18 |
| Support Level | $2.89 | N/A |
| Resistance Level | $8.35 | $5.15 |
| Average True Range (ATR) | 0.81 | 0.21 |
| MACD | -0.20 | -0.00 |
| Stochastic Oscillator | 13.46 | 12.00 |
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.